Lupus Anticoagulant Testing in Patients Receiving Rivaroxaban or Apixaban for the Treatment of Venous Thromboembolism

被引：0
|
作者：
Kovacs, Matthew R. [1 ]
Lazo-Langner, Alejandro [2 ]
Louzada, Martha L. [1 ]
Kovacs, Michael J. [3 ]
机构：
[1] London Hlth Sci Ctr, London, ON, Canada
[2] Univ Western Ontario, Div Hematol, Dept Med, London, ON, Canada
[3] London Hlth Sci Ctr, Div Hematol, Dept Med, London, ON, Canada
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5017.5017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] LUPUS ANTICOAGULANT TESTING IS UNINTERPRETABLE IN PATIENTS RECEIVING RIVAROXABAN THERAPY FOR VENOUS THROMBOEMBOLISM TREATMENT
    Kaplan, Z.
    Butler, J.
    Malan, E.
    Gan, E.
    Tran, H.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 289 - 290
  • [2] Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism
    Kovacs, Matthew R.
    Lazo-Langner, Alejandro
    Louzada, Martha L.
    Kovacs, Michael J.
    [J]. THROMBOSIS RESEARCH, 2020, 195 : 231 - 232
  • [3] Apixaban or rivaroxaban in the treatment of acute venous thromboembolism?
    Hellfritzsch, Maja
    Grove, Erik L.
    Adelborg, Kasper
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [4] Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism
    Bott-Kitslaar, Dalene M.
    McBane, Robert D.
    Casanegra, Ana I.
    Houghton, Damon E.
    Froehling, David A.
    Vlazny, Danielle T.
    Ashrani, Aneel A.
    Hodge, David O.
    Vargas, Emily R.
    Bartlett, Matthew A.
    Saadiq, Rayya A.
    Daniels, Paul R.
    Shields, Raymond C.
    Lenz, Charles J.
    Lang, Teresa R.
    Wysokinski, Waldemar E.
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (07) : 1242 - 1252
  • [5] APIXABAN AND RIVAROXABAN VERSUS WARFARIN FOR TREATMENT OF VENOUS THROMBOEMBOLISM IN OBESE PATIENTS
    Kafka, Wesley
    Cook, Stephen
    Ferris, Jessica
    Hill, Sharon
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [6] Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism
    Trujillo-Santosa, Javier
    Beroizb, Patricia
    Moustafac, Fares
    Alonso, Alicia
    Morejon, Estrella
    Lopez-Reyes, Raquel
    Casado, Ignacio
    Porras, Jose Antonio
    Flores, Katia
    Lopez-Nunez, Juan J.
    Monrealj, Manuel
    [J]. THROMBOSIS RESEARCH, 2020, 193 : 160 - 165
  • [7] Plasma levels of apixaban and rivaroxaban in patients with venous thromboembolism
    Paskaleva, I.
    Doncheva, E.
    [J]. CLINICA CHIMICA ACTA, 2024, 558
  • [8] Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location
    Janczak, Dawid T.
    Mimier, Malgorzata K.
    McBane, Robert D.
    Kamath, Patrick S.
    Simmons, Benjamin S.
    Bott-Kitslaar, Dalene M.
    Lenz, Charles J.
    Vargas, Emily R.
    Hodge, David O.
    Wysokinski, Waldemar E.
    [J]. MAYO CLINIC PROCEEDINGS, 2018, 93 (01) : 40 - 47
  • [9] Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study
    Sindet-Pedersen, Caroline
    Staerk, Laila
    Pallisgaard, Jannik Langtved
    Gerds, Thomas Alexander
    Berger, Jeffrey S.
    Torp-Pedersen, Christian
    Gislason, Gunnar H.
    Olesen, Jonas Bjerring
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2018, 4 (04) : 220 - 227
  • [10] Apixaban for the Treatment of venous Thromboembolism in Cancer Patients
    Barutcu, Atakan Goerkem
    Alakus, Hakan
    Bruns, Christiane
    [J]. ONKOLOGE, 2020, 26 (08): : 758 - 759
12345